Cinryze Articles

Stagnant treatment future seen for inherited orphan blood diseases

23 January 2013

ViroPharma gets FDA backing for industrial scale Cinryze manufacturing

7 August 2012

ViroPharma's Cinryze cleared for hereditary angioedema in Europe

17 June 2011

ViroPharma in up to $83 million deal with Halozyme for rHuPH 20 with Cinryze

12 May 2011

Batch of positive and negative drug opinions from Europe’s CHMP

21 March 2011

FDA priority review for ViroPharma's Cinryze

9 February 2009

Nine likelypharmaceutical M&Adeals in 2009 projected by Zachs' analysts

19 January 2009

Cinryze achieves 30 min symptom improvement

1 December 2008

Lev gets OK for Cinryze ahead of merger

20 October 2008

Lev Pharma submits Cinryze to EMEA

7 July 2008

Lev Pharma in plasma supply deal

21 April 2008

US FDA requests more CMC information on Lev's Cinryze

11 February 2008

Cinryze shows promise as acute HAE treatment

19 November 2007

Lev's Cinryze achieves primary endpoint in Ph III HAE trial

17 September 2007

Showing 1-14 of 14 articles

Go to beginningPrevious
  • 1
NextGo to end